Somers Deirdre

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 21% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Somers Deirdre's trades of Enfusion Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
289.81
Quantity 97,135
Value US$804,061
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
13.01
Quantity 60,918 -9.9%
Value US$4,961,371
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
287.93
Quantity 65,390
Value US$3,112,810
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
8.40
Quantity 4,629 -9.7%
Value US$38,884
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
8.40
Quantity 4,629
Value US$38,898
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
8.65
Quantity 1,770 -4.9%
Value US$15,310
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
8.64
Quantity 1,770
Value US$15,301
Transaction date
Purchase
Price
4.74
Quantity 3,940
Value £18,676
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-15 2025-04-15
US Enfusion Inc (ENFN)
PrS Proposed sale
97,135
289.81
US$804,061 		97,135 289.81 US$804,061
2025-01-15 2025-01-13
US Enfusion Inc (ENFN)
S Sale
60,918 -9.9%
13.01
US$4,961,371 		60,918 -9.9% 13.01 US$4,961,371
2025-01-13 2025-01-13
US Enfusion Inc (ENFN)
PrS Proposed sale
65,390
287.93
US$3,112,810 		65,390 287.93 US$3,112,810
2024-06-17 2024-06-14
US Enfusion Inc (ENFN)
S Sale
4,629 -9.7%
8.40
US$38,884 		4,629 -9.7% 8.40 US$38,884
2024-06-14 2024-06-14
US Enfusion Inc (ENFN)
PrS Proposed sale
4,629
8.40
US$38,898 		4,629 8.40 US$38,898
2024-01-12 2024-01-10
US Enfusion Inc (ENFN)
S Sale
1,770 -4.9%
8.65
US$15,310 		1,770 -4.9% 8.65 US$15,310
2024-01-10 2024-01-10
US Enfusion Inc (ENFN)
PrS Proposed sale
1,770
8.64
US$15,301 		1,770 8.64 US$15,301
2021-03-26 2021-03-24
B Purchase
3,940
4.74
£18,676 		3,940 4.74 £18,676